Investigating how a specific transporter affects pancreatitis caused by alcohol
Role of the ER acetyl CoA transporter in alcoholic pancreatitis
This study is looking at how alcohol and smoking can mess up the way proteins work in the pancreas, which might lead to painful pancreatitis, and it hopes to find new ways to help people manage or prevent this condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Wisconsin-Madison NIH-funded |
| Lab location | 1 site (Madison, United States) |
| Project ID | NIH-11035067 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of the endoplasmic reticulum (ER) acetyl CoA transporter in the development of alcoholic pancreatitis, a painful condition affecting the pancreas. The study examines how alcohol and smoking disrupt normal protein folding and transport in pancreatic cells, leading to disease. By exploring the molecular mechanisms involved, the research aims to identify potential therapeutic targets that could help prevent or treat chronic pancreatitis. Patients may benefit from insights gained into how their condition is affected by lifestyle factors like alcohol consumption.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from chronic pancreatitis, particularly those with a history of alcohol use.
Not a fit: Patients who do not have chronic pancreatitis or those whose condition is unrelated to alcohol consumption may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that prevent or alleviate the symptoms of alcoholic pancreatitis.
How similar studies have performed: Previous research has shown promising results in understanding the mechanisms of pancreatitis, but this specific approach is relatively novel.
Where this research is happening
Madison, United States
- University of Wisconsin-Madison — Madison, United States (Active)
Researchers
- Principal investigator: Groblewski, Guy E — University of Wisconsin-Madison
- Study coordinator: Groblewski, Guy E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.